Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 21, 2026

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

Novel bioartificial liver support system: preclinical evaluation.

J F Patzer1, G V Mazariegos, R Lopez

  • 1Department of Surgery, University of Pittsburgh, Pennsylvania 15213-2582, USA. patzer+@pitt.edu

Annals of the New York Academy of Sciences
|July 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First report of full colon transplantation as part of a visceral allograft.

Techniques in coloproctology·2025
Same author

Comparison of the immobilisation and cardiorespiratory effects of thiafentanil-azaperone versus thiafentanil-medetomidine-azaperone in African buffalo (<i>Syncerus caffer</i>).

Journal of the South African Veterinary Association·2025
Same author

Work-related musculoskeletal pain and discomfort in laparoscopic surgeons: an international multispecialty survey.

Annals of the Royal College of Surgeons of England·2023
Same author

A systematic review of point-of-care abdominal ultrasound scans performed by general surgeons in paediatric patients.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2023
Same author

Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.

Experimental neurology·2022
Same author

Effectiveness of two tobacco cessation methods among TB patients.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
Same journal

Synchrony and Reciprocity in Rhythmic Interaction.

Annals of the New York Academy of Sciences·2026
Same journal

Leveraging Salt Fortification Platforms to Address Multiple-Micronutrient Deficiencies in Africa: A Policy Opportunity.

Annals of the New York Academy of Sciences·2026
See all related articles

This study shows a novel bioartificial liver support system (BLSS) significantly prolonged survival in a canine liver failure model. The BLSS, housing porcine hepatocytes, offers a promising preclinical evaluation for human liver disease treatment.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Preclinical Research

Background:

  • Acute liver failure (ALF) presents a critical unmet medical need.
  • Current treatments for ALF are limited, necessitating innovative therapeutic strategies.
  • Bioartificial liver support systems (BLSS) offer a potential solution by bridging patients to liver transplantation or recovery.

Purpose of the Study:

  • To evaluate the preclinical safety and efficacy of a novel bioartificial liver support system (BLSS).
  • To assess the impact of BLSS treatment timing on survival in a canine model of D-galactosamine-induced liver failure.

Main Methods:

  • A D-galactosamine canine liver failure model was established.
  • Porcine hepatocytes were cultured within a hollow fiber cartridge, forming the BLSS.

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

An All-Human Hepatic Culture System for Drug Development Applications
07:23

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

An All-Human Hepatic Culture System for Drug Development Applications
07:23

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

  • Canine subjects received D-galactosamine and were divided into control and BLSS treatment groups with varying treatment initiation times.
  • Physiological parameters, including blood pressure, intracranial pressure, and liver enzymes, were continuously monitored.

    • Main Results:

    • All animals developed severe liver failure, characterized by hemodynamic instability, elevated intracranial pressure, hepatocellular damage, and metabolic acidosis.
    • BLSS treatment, initiated at 16-18 hours or 24-26 hours post-D-galactosamine administration, significantly prolonged survival compared to the control group (p=0.047).
    • No significant difference in survival was observed between the two BLSS treatment initiation times (p=0.694).

    Conclusions:

    • The novel bioartificial liver support system (BLSS) demonstrates significant efficacy in prolonging survival in a preclinical canine model of acute liver failure.
    • The findings support the readiness of this BLSS for Phase I clinical safety evaluation.
    • This BLSS holds promise as a therapeutic option for patients suffering from acute liver failure.